2 results
Approved WMOPending
To study the impact on intra-arterial ATP infusion on Annexin A5 targeting.
Approved WMOCompleted
Primary Study Objective:To assess the efficacy and safety of the co-administration of low-dose pegvisomant (40 mg, administered via subcutaneous injection given once a week) and long-acting somatostatin analogs (administered once monthly) on the…